As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

POC tests are performed in a wide range of geographical locations such as:

• Hospital departments such as emergency departments, operating rooms, intensive care units, and others
• Physicians’ offices
• Hospital clinics
• Rural health clinics
• Student health clinics
• Retail clinics
• Pharmacies
• Homes – With testing performed by patients, visiting nurses, or other caregivers
• Nursing homes
• Prisons

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

The menu for point-of-care testing continues to expand.  The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

In the past 5-10 years the following tests were added: HbA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use.  At the same time, more decentralized test venues invest in non-waived rapid tests and instruments.  POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care.  New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

• 1 Step Detec Associats
• Abbott Laboratories
• Abingdon Health
• Access Bio
• AccuBioTech Co
• ACON Laboratories
• Aerscher Diagnostics
• Akers Biosciences
• Alfa Scientific Designs
• American Bio Medica
• ARKRAY
• Artron Laboratories
• Ascensia Diabetes Care
• Ativa Medical Corp
• Atlas Link Biotech
• Audit Diagnostics
• Autobio Diagnostics
• Beckman Coulter
• Becton Dickinson
• Beijing Wantai Biological Pharmaceuticals
• Bhat Bio-Tech India Private Ltd.
• Binx health
• bioLytical Laboratories
• BioMedomics
• Biomeme
• Biomerica
• bioMérieux SA
• Bio-Rad Laboratories
• Biosensia
• Biotron Diagnostics
• Boditech Med
• Boson Biotech
• BTNX
• Calypte Biomedical Corp
• Cepheid
• Chembio Diagnostics
• Church & Dwight
• Clarity Diagnostics
• Confirm Biosciences
• CTK Biotech
• Danaher Corporation
• Dexcom
• DIALAB
• DiaSys Diagnostic Systems
• Diazyme Laboratories
• DNA Electronics Ltd. (DNAe)
• Dr Fooke-Achterrath
• DxGen
• Eiken Chemical
• EKF Diagnostics
• ELITechGroup, Inc
• Enterix (Clinical Genomics)
• Eurobio Scientific
• Everlywell
• Exact Sciences
• EY Laboratories
• First Check Diagnostics
• GenBio
• Genedrive
• GenePOC
• GeTein Biotech Inc.
• GlysBy
• Helena Labs
• Hemosure
• HORIBA
• Immunosciences Lab
• Immunostics
• J. Mitra & Co Pvt
• JAL Innovation
• Jant Pharmacal
• LamdaGen Corp
• LifeScan
• LifeSign
• LightDeck Diagnostics
• Macherey-Nagel
• Medix Biochemica
• MedMira
• Medtronic
• A. Menarini Diagnostics
• Meridian BioScience
• MiCo BioMed USA
• Nano-Ditech Corporation
• NG Biotech
• Noble Medical
• Nova Biomedical
• NuGenerex Diagnostics
• Oasis Diagnostics
• Operon
• OPKO Health
• OraSure Technologies
• Polymedco
• Polymer Technologies (PTS Diagnostics)
• Preventis
• Princeton Biomeditech
• QuantuMDx Group
• Quidel
• Radiometer Medical
• Randox Labs
• RENESA UG
• Response Biomedical
• Reszon Diagnostics
• Rheonix
• Roche Diagnostics
• Savyon Diagnostics
• Sekisui Diagnostics
• Siemens Healthcare
• Sysmex
• TECHLAB
• Trinity Biotech
• Trividia Health
• Tulip Diagnostics
• VedaLab
• Veredus Laboratories
• Werfen

Scope and Methodology 

The  geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers.  Additionally, key company profiles are included. 

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2021, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2021-2026 periods for each segment covered.  Competitive analysis is provided for the year 2021 along with regional breakdowns.  The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.